IBDEI2DS ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,37998,2)
;;=^5007827
;;^UTILITY(U,$J,358.3,37999,0)
;;=L98.0^^146^1925^21
;;^UTILITY(U,$J,358.3,37999,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,37999,1,3,0)
;;=3^Pyogenic granuloma
;;^UTILITY(U,$J,358.3,37999,1,4,0)
;;=4^L98.0
;;^UTILITY(U,$J,358.3,37999,2)
;;=^5009574
;;^UTILITY(U,$J,358.3,38000,0)
;;=L40.0^^146^1925^16
;;^UTILITY(U,$J,358.3,38000,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,38000,1,3,0)
;;=3^Psoriasis vulgaris
;;^UTILITY(U,$J,358.3,38000,1,4,0)
;;=4^L40.0
;;^UTILITY(U,$J,358.3,38000,2)
;;=^5009160
;;^UTILITY(U,$J,358.3,38001,0)
;;=L40.1^^146^1925^19
;;^UTILITY(U,$J,358.3,38001,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,38001,1,3,0)
;;=3^Pustular Psoriasis,Generalized
;;^UTILITY(U,$J,358.3,38001,1,4,0)
;;=4^L40.1
;;^UTILITY(U,$J,358.3,38001,2)
;;=^5009161
;;^UTILITY(U,$J,358.3,38002,0)
;;=L40.9^^146^1925^17
;;^UTILITY(U,$J,358.3,38002,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,38002,1,3,0)
;;=3^Psoriasis, unspec
;;^UTILITY(U,$J,358.3,38002,1,4,0)
;;=4^L40.9
;;^UTILITY(U,$J,358.3,38002,2)
;;=^5009171
;;^UTILITY(U,$J,358.3,38003,0)
;;=L40.3^^146^1925^20
;;^UTILITY(U,$J,358.3,38003,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,38003,1,3,0)
;;=3^Pustulosis palmaris et plantaris
;;^UTILITY(U,$J,358.3,38003,1,4,0)
;;=4^L40.3
;;^UTILITY(U,$J,358.3,38003,2)
;;=^5009163
;;^UTILITY(U,$J,358.3,38004,0)
;;=L40.8^^146^1925^15
;;^UTILITY(U,$J,358.3,38004,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,38004,1,3,0)
;;=3^Psoriasis NEC
;;^UTILITY(U,$J,358.3,38004,1,4,0)
;;=4^L40.8
;;^UTILITY(U,$J,358.3,38004,2)
;;=^271917
;;^UTILITY(U,$J,358.3,38005,0)
;;=L40.4^^146^1925^18
;;^UTILITY(U,$J,358.3,38005,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,38005,1,3,0)
;;=3^Psoriasis,Guttate
;;^UTILITY(U,$J,358.3,38005,1,4,0)
;;=4^L40.4
;;^UTILITY(U,$J,358.3,38005,2)
;;=^5009164
;;^UTILITY(U,$J,358.3,38006,0)
;;=M72.2^^146^1925^9
;;^UTILITY(U,$J,358.3,38006,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,38006,1,3,0)
;;=3^Plantar fascial fibromatosis
;;^UTILITY(U,$J,358.3,38006,1,4,0)
;;=4^M72.2
;;^UTILITY(U,$J,358.3,38006,2)
;;=^272598
;;^UTILITY(U,$J,358.3,38007,0)
;;=M15.9^^146^1925^10
;;^UTILITY(U,$J,358.3,38007,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,38007,1,3,0)
;;=3^Polyosteoarthritis,Unspec
;;^UTILITY(U,$J,358.3,38007,1,4,0)
;;=4^M15.9
;;^UTILITY(U,$J,358.3,38007,2)
;;=^5010768
;;^UTILITY(U,$J,358.3,38008,0)
;;=I87.002^^146^1925^13
;;^UTILITY(U,$J,358.3,38008,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,38008,1,3,0)
;;=3^Postthrom syndr w/o compl of lft lwr extrem
;;^UTILITY(U,$J,358.3,38008,1,4,0)
;;=4^I87.002
;;^UTILITY(U,$J,358.3,38008,2)
;;=^5008028
;;^UTILITY(U,$J,358.3,38009,0)
;;=I73.9^^146^1925^2
;;^UTILITY(U,$J,358.3,38009,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,38009,1,3,0)
;;=3^Peripheral Vascular Disease,Unspec
;;^UTILITY(U,$J,358.3,38009,1,4,0)
;;=4^I73.9
;;^UTILITY(U,$J,358.3,38009,2)
;;=^184182
;;^UTILITY(U,$J,358.3,38010,0)
;;=M06.372^^146^1926^13
;;^UTILITY(U,$J,358.3,38010,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,38010,1,3,0)
;;=3^Rheumatoid nodule, left Ankle/Foot
;;^UTILITY(U,$J,358.3,38010,1,4,0)
;;=4^M06.372
;;^UTILITY(U,$J,358.3,38010,2)
;;=^5010116
;;^UTILITY(U,$J,358.3,38011,0)
;;=M06.371^^146^1926^14
;;^UTILITY(U,$J,358.3,38011,1,0)
;;=^358.31IA^4^2
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI2DS 3764 printed Apr 09, 2024@21:36:59 Page 2
IBDEI2DS ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,37998,2)
+2 ;;=^5007827
+3 ;;^UTILITY(U,$J,358.3,37999,0)
+4 ;;=L98.0^^146^1925^21
+5 ;;^UTILITY(U,$J,358.3,37999,1,0)
+6 ;;=^358.31IA^4^2
+7 ;;^UTILITY(U,$J,358.3,37999,1,3,0)
+8 ;;=3^Pyogenic granuloma
+9 ;;^UTILITY(U,$J,358.3,37999,1,4,0)
+10 ;;=4^L98.0
+11 ;;^UTILITY(U,$J,358.3,37999,2)
+12 ;;=^5009574
+13 ;;^UTILITY(U,$J,358.3,38000,0)
+14 ;;=L40.0^^146^1925^16
+15 ;;^UTILITY(U,$J,358.3,38000,1,0)
+16 ;;=^358.31IA^4^2
+17 ;;^UTILITY(U,$J,358.3,38000,1,3,0)
+18 ;;=3^Psoriasis vulgaris
+19 ;;^UTILITY(U,$J,358.3,38000,1,4,0)
+20 ;;=4^L40.0
+21 ;;^UTILITY(U,$J,358.3,38000,2)
+22 ;;=^5009160
+23 ;;^UTILITY(U,$J,358.3,38001,0)
+24 ;;=L40.1^^146^1925^19
+25 ;;^UTILITY(U,$J,358.3,38001,1,0)
+26 ;;=^358.31IA^4^2
+27 ;;^UTILITY(U,$J,358.3,38001,1,3,0)
+28 ;;=3^Pustular Psoriasis,Generalized
+29 ;;^UTILITY(U,$J,358.3,38001,1,4,0)
+30 ;;=4^L40.1
+31 ;;^UTILITY(U,$J,358.3,38001,2)
+32 ;;=^5009161
+33 ;;^UTILITY(U,$J,358.3,38002,0)
+34 ;;=L40.9^^146^1925^17
+35 ;;^UTILITY(U,$J,358.3,38002,1,0)
+36 ;;=^358.31IA^4^2
+37 ;;^UTILITY(U,$J,358.3,38002,1,3,0)
+38 ;;=3^Psoriasis, unspec
+39 ;;^UTILITY(U,$J,358.3,38002,1,4,0)
+40 ;;=4^L40.9
+41 ;;^UTILITY(U,$J,358.3,38002,2)
+42 ;;=^5009171
+43 ;;^UTILITY(U,$J,358.3,38003,0)
+44 ;;=L40.3^^146^1925^20
+45 ;;^UTILITY(U,$J,358.3,38003,1,0)
+46 ;;=^358.31IA^4^2
+47 ;;^UTILITY(U,$J,358.3,38003,1,3,0)
+48 ;;=3^Pustulosis palmaris et plantaris
+49 ;;^UTILITY(U,$J,358.3,38003,1,4,0)
+50 ;;=4^L40.3
+51 ;;^UTILITY(U,$J,358.3,38003,2)
+52 ;;=^5009163
+53 ;;^UTILITY(U,$J,358.3,38004,0)
+54 ;;=L40.8^^146^1925^15
+55 ;;^UTILITY(U,$J,358.3,38004,1,0)
+56 ;;=^358.31IA^4^2
+57 ;;^UTILITY(U,$J,358.3,38004,1,3,0)
+58 ;;=3^Psoriasis NEC
+59 ;;^UTILITY(U,$J,358.3,38004,1,4,0)
+60 ;;=4^L40.8
+61 ;;^UTILITY(U,$J,358.3,38004,2)
+62 ;;=^271917
+63 ;;^UTILITY(U,$J,358.3,38005,0)
+64 ;;=L40.4^^146^1925^18
+65 ;;^UTILITY(U,$J,358.3,38005,1,0)
+66 ;;=^358.31IA^4^2
+67 ;;^UTILITY(U,$J,358.3,38005,1,3,0)
+68 ;;=3^Psoriasis,Guttate
+69 ;;^UTILITY(U,$J,358.3,38005,1,4,0)
+70 ;;=4^L40.4
+71 ;;^UTILITY(U,$J,358.3,38005,2)
+72 ;;=^5009164
+73 ;;^UTILITY(U,$J,358.3,38006,0)
+74 ;;=M72.2^^146^1925^9
+75 ;;^UTILITY(U,$J,358.3,38006,1,0)
+76 ;;=^358.31IA^4^2
+77 ;;^UTILITY(U,$J,358.3,38006,1,3,0)
+78 ;;=3^Plantar fascial fibromatosis
+79 ;;^UTILITY(U,$J,358.3,38006,1,4,0)
+80 ;;=4^M72.2
+81 ;;^UTILITY(U,$J,358.3,38006,2)
+82 ;;=^272598
+83 ;;^UTILITY(U,$J,358.3,38007,0)
+84 ;;=M15.9^^146^1925^10
+85 ;;^UTILITY(U,$J,358.3,38007,1,0)
+86 ;;=^358.31IA^4^2
+87 ;;^UTILITY(U,$J,358.3,38007,1,3,0)
+88 ;;=3^Polyosteoarthritis,Unspec
+89 ;;^UTILITY(U,$J,358.3,38007,1,4,0)
+90 ;;=4^M15.9
+91 ;;^UTILITY(U,$J,358.3,38007,2)
+92 ;;=^5010768
+93 ;;^UTILITY(U,$J,358.3,38008,0)
+94 ;;=I87.002^^146^1925^13
+95 ;;^UTILITY(U,$J,358.3,38008,1,0)
+96 ;;=^358.31IA^4^2
+97 ;;^UTILITY(U,$J,358.3,38008,1,3,0)
+98 ;;=3^Postthrom syndr w/o compl of lft lwr extrem
+99 ;;^UTILITY(U,$J,358.3,38008,1,4,0)
+100 ;;=4^I87.002
+101 ;;^UTILITY(U,$J,358.3,38008,2)
+102 ;;=^5008028
+103 ;;^UTILITY(U,$J,358.3,38009,0)
+104 ;;=I73.9^^146^1925^2
+105 ;;^UTILITY(U,$J,358.3,38009,1,0)
+106 ;;=^358.31IA^4^2
+107 ;;^UTILITY(U,$J,358.3,38009,1,3,0)
+108 ;;=3^Peripheral Vascular Disease,Unspec
+109 ;;^UTILITY(U,$J,358.3,38009,1,4,0)
+110 ;;=4^I73.9
+111 ;;^UTILITY(U,$J,358.3,38009,2)
+112 ;;=^184182
+113 ;;^UTILITY(U,$J,358.3,38010,0)
+114 ;;=M06.372^^146^1926^13
+115 ;;^UTILITY(U,$J,358.3,38010,1,0)
+116 ;;=^358.31IA^4^2
+117 ;;^UTILITY(U,$J,358.3,38010,1,3,0)
+118 ;;=3^Rheumatoid nodule, left Ankle/Foot
+119 ;;^UTILITY(U,$J,358.3,38010,1,4,0)
+120 ;;=4^M06.372
+121 ;;^UTILITY(U,$J,358.3,38010,2)
+122 ;;=^5010116
+123 ;;^UTILITY(U,$J,358.3,38011,0)
+124 ;;=M06.371^^146^1926^14
+125 ;;^UTILITY(U,$J,358.3,38011,1,0)
+126 ;;=^358.31IA^4^2
